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Editorial on the Research Topic
Chemicals in the Environment and Brain Development: Importance of Neuroendocrinological
Approaches
In the past three decades, a sharp increase in the number of children diagnosed with
neurodevelopmental disorders has been observed; the reason for this is not well-explained
(Weintraub, 2011). The human genome does not change rapidly; this suggests that non-genetic
factors are the driving forces of this dramatic surge. Several reports, including epidemiological
studies, have found an association between in utero and childhood exposure to certain
environmental chemicals and children’s brain development. Yet, the mechanisms by which these
chemicals impair brain development and function are not fully understood. In addition, how
these chemicals enter and accumulate in the brain are still unknown. Experimental approaches
are essential to understand how those harmful chemicals enter children’s brain and pose discrete
effects on specific brain sites. These approaches include the following: improvement of technologies
for the detection and measurement of neuroendocrinological and behavioral changes in animal
models: development of analytical methods for the identification and quantification of chemicals
and their metabolites in the brain; development of in vitro cell line assays; and imaging technologies
to illustrate cellular functions.
In this Research Topic, we collected articles that provide state-of-the-art science and
technologies that can help us identify environmental chemicals that influence brain development.
We also included articles that lead to a better understanding of the actions and dynamics of these
chemicals. As summarized in the review by Fujiwara et al. certain chemical exposures such as
atmospherically released chemicals (volatile organic chemicals and pesticides), metals, endocrine
disruptors, and psychoactive pharmaceuticals are associated with an increased risk of autism
spectrum disorder, a neurodevelopmental disorder. Thus, we especially encouraged researchers to
submit their works that are related to fetal and early childhood (i.e., early-life) exposure to these
chemicals.
Among volatile organic chemicals,Win-Shwe et al. revealed that early-life exposure to secondary
organic aerosol, a component of particulate matter (PM), especially PM2.5, impairs social memory
in adulthood; this was demonstrated using the murine three-chamber test. As for pesticides,
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recent studies have suggested the possibility that neonicotinoids,
which are known to overstimulate insect nicotinic acetylcholine
receptors and kill insects, also impair neuronal transmission
in the mammalian brain. Sano et al. elucidated the effect of
developmental exposure to acetamiprid, a neonicotinoid, on
murine behavioral profiles in adulthood; their study confirmed
the transfer of acetamiprid to the developing brain. They revealed
that exposure to acetamiprid induces abnormalities in socio-
sexual and anxiety-related behaviors in sex- and dose-dependent
manners.
Lead, mercury, and arsenic are infamous as neurotoxic
chemicals. Early-life exposures to these metals might be related
to the increased risk in neurodevelopmental disorders. Since
more than 200 million people worldwide have been estimated
to be exposed to arsenic from drinking water and food,
experimental studies on its effects on the developing brain
are required to evaluate whether early-life exposure to arsenic
at environmentally relevant doses causes neurodevelopmental
disorders. Aung et al. found that mice exposed to arsenic in utero
displayed an impaired adaptation to repetitive reversal tasks, one
of the typical features of autistic spectrum disorder. They also
found that the neurite length of neurons in the prelimbic cortex
is significantly reduced in the mice exposed to arsenic in utero;
this suggests the possibility that impaired formation of neural
connections in the prelimbic cortex is one of the causes of the
observed behavioral abnormality. In the brain, astrocytes could
also be affected by arsenic neurotoxicity. Htike et al. developed
a method to evaluate the effect of arsenic exposure on the cell
cycle of primary cultured cortical astrocytes using transgenic
mice expressing a fluorescence protein indicator, which enabled
the visualization of the cell cycle. Using this method, they found
that arsenic exposure led to early entry to mitotic S-phase
and subsequently induced cell death. The mechanisms of the
transport into the brain and the neurotoxicity of metals are not
yet fully understood. Ximenes-da-Silva reviewed the biological
route through which metal ions is transported and focused on a
metal transporter, aquaporin-4. On the toxicity of metals, Harada
et al. suggested that gliotransmitter release from astrocytes needs
to be investigated as a new target of metal ions.
Among endocrine-disrupting chemicals, bisphenol A has
been demonstrated to possess an estrogenic activity in many
experimental models. Cano-Nicolau et al. developed a method
to detect Cyp19a1 and Cyp19b1 promoter activities by in
vivo imaging of transgenic zebrafish expressing the green
fluorescent protein (GFP) under the control of either Cyp19a1
or Cyp19b1 promoters. They revealed that bisphenol A
and its substitutes have strong estrogenic activities. Apart
from exhibiting estrogenic activity, bisphenol A and related
compounds also have broad toxicological effects. Ling et al.
established a method to visualize the neuronal migration
in the cerebral cortex using in utero electroporation of a
plasmid expressing a fluorescent protein. They demonstrated
that exposure to bisphenol A during the late embryonic period
in mice disturbed neuronal migration and impaired gene
expression of neurotrophic factor receptor tropomyosin receptor
kinase B (TrkB). The mode of action for endocrine-disrupting
chemicals includes epigenetic effects. Derghal et al. reviewed how
exposure to certain endocrine-disrupting chemicals changed the
expression of microRNA and thereby caused endocrine diseases
and disorders.
Exposure to psychoactive pharmaceuticals could affect brain
development. Furukawa et al. revealed that the administration
of benzodiazepines to mice during the juvenile period caused
irreversible learning and memory deficits; this suggests that an
extraordinary amount of care is required for prescription of
benzodiazepines to juveniles. Steinberg and Moreira reviewed
the risk of treatment of pregnant women diagnosed with acute
ischemic stroke with recombinant tissue plasminogen activator,
which has been shown to have neuroendocrine effects in
vasopressin secretion. Although tissue plasminogen activator has
been generally avoided in pregnant women, the authors claimed
that the treatment risk must be balanced against the potential of
maternal health risk of ischemic stroke.
To elaborate the precise mechanism of the effect of early-
life exposure to environmental chemicals and use the knowledge
for prevention and intervention, the development of alternative
animal models that enable the detection of subtle physiological,
anatomical, and functional alterations is an urgent matter.
Kawashima et al. reviewed how avian models could be used
to evaluate developmental abnormalities of the neurologic and
reproductive systems. Animal models could be also used to detect
compounds that counteract the harmful effects of environmental
factors. Ge et al. established the rat model of subclinical
hypothyroidism using partial thyroid electrocauterization and
found that resveratrol ameliorated the anxiety- and depression-
like behaviors. Goto et al. reviewed the murine depression
model for future detection of antidepressant-like effects of
chemicals.
The articles in this Research Topic, by applying newly
established methods, supplied novel information about harmful
endpoints of environmental chemicals such as secondary organic
aerosol, neonicotinoid, arsenic, bisphenol A, and psychoactive
pharmaceuticals. The reviews demonstrated the typical and
novel interactions between environmental chemicals and the
developing brain. We believe that these studies would lead to
further understanding of neurodevelopmental disorders caused
by environmental factors.
AUTHOR CONTRIBUTIONS
All authors listed directly contributed to the writing and
approved the manuscript for publication.
FUNDING
This work was partly supported by the National Institute for
Environmental Studies (1416AT001).
ACKNOWLEDGMENTS
We appreciate the efforts of all the contributors for this research
topic.
Frontiers in Neuroscience | www.frontiersin.org 2 March 2017 | Volume 11 | Article 133
Maekawa et al. Chemicals and Brain Development
REFERENCES
Weintraub, K. (2011). The prevalence puzzle: autism counts. Nature 479, 22–24.
doi: 10.1038/479022a
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Maekawa, Nakamura and Nakayama. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Neuroscience | www.frontiersin.org 3 March 2017 | Volume 11 | Article 133
